Pacific Biosciences of California, Inc. PACB Income Statement

Pacific biosciences of california, inc. (PACB)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11
Revenue:
Revenue
90,064	90,891	82,487	78,732	75,689	78,626	84,035	89,420	87,915	93,468	94,255	95,828	96,502	90,714	101,273	90,072	94,264	92,782	73,405	80,111	66,597	60,594	52,824	39,622	34,245	28,181	24,925	20,280	21,523	25,983	32,549	40,292	43,631	33,863	0	0	0
Cost of revenue:
Cost of revenue
53,117	56,315	55,097	55,064	52,772	53,530	55,191	55,541	54,897	58,809	57,716	54,878	52,909	46,554	42,021	36,907	37,237	39,332	41,983	42,078	39,944	37,192	30,671	29,390	26,080	21,762	21,068	17,474	19,501	25,043	26,983	27,128	0	-	0	0	-
Gross profit
36,947	34,576	27,390	23,668	22,917	25,096	28,844	33,879	33,018	34,659	36,539	40,950	43,593	44,160	59,252	53,165	57,027	53,450	31,422	38,033	26,653	23,402	22,153	10,232	8,165	6,419	3,857	2,806	2,022	940	1,850	4,988	12,612	13,034	0	0	0
Operating expense:
Research and development
59,395	59,630	61,620	61,014	61,768	62,594	61,957	63,445	64,664	65,324	65,953	67,588	68,227	67,617	66,114	64,797	62,318	60,440	58,019	53,550	50,942	48,230	47,032	45,758	45,005	45,217	45,736	47,943	47,533	47,623	48,386	55,761	64,035	76,080	0	0	0
Sales, general and administrative
80,672	75,491	79,021	72,461	68,321	63,489	57,780	58,226	58,788	59,119	57,715	55,657	51,344	47,787	47,570	46,494	46,123	45,187	42,412	41,476	39,648	38,026	37,085	37,960	38,341	38,745	40,354	39,740	41,924	47,655	48,797	51,418	50,876	46,710	0	0	0
Gain on lease amendments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total operating expense
140,067	135,121	140,641	133,475	130,089	126,083	119,737	121,671	123,452	124,443	123,668	123,245	119,571	115,404	113,684	88,248	85,398	82,584	77,388	95,026	90,590	86,256	84,117	83,718	83,346	83,962	86,090	87,683	89,457	95,278	97,183	107,179	114,911	122,790	0	0	0
Operating loss
-103,120	-100,545	-113,251	-109,807	-107,172	-100,987	-90,893	-87,792	-90,434	-89,784	-87,129	-82,295	-75,978	-71,244	-54,432	-35,083	-28,371	-29,134	-45,966	-56,993	-63,937	-62,854	-61,964	-73,486	-75,181	-77,543	-82,233	-84,877	-87,435	-94,338	-95,333	-102,191	-102,299	-109,756	0	0	0
Gain from Continuation Advances
0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest expense
2,253	2,611	2,561	2,513	2,467	2,423	2,419	2,436	2,664	2,921	3,136	3,324	3,293	3,234	3,168	3,088	3,008	2,926	2,878	2,853	2,839	2,828	2,796	2,766	2,738	2,478	1,853	1,236	0	-	0	0	-	-	-	-	-
Other income, net
825	1,022	970	1,557	932	848	787	726	597	516	-192	-311	381	103	846	732	504	364	-418	-400	-671	-478	344	512	844	728	424	208	146	147	138	376	427	655	0	0	0
Net income (loss)
-52,548	-84,134	-114,842	-110,763	-108,707	-102,562	-92,525	-89,502	-92,501	-92,189	-90,457	-85,930	-78,890	-74,375	-56,754	-37,439	-30,875	-31,696	-49,262	-60,246	-67,447	-66,160	-64,416	-75,740	-77,075	-79,293	-83,731	-85,973	-87,989	-94,465	-95,619	-102,171	-102,159	-109,388	0	0	0
Other comprehensive income (loss):
Unrealized gain on investments
24	41	35	33	44	-4	-22	0	-35	-37	-25	-68	-44	12	17	40	25	-16	-17	-30	-2	-5	12	44	7	-16	-55	-77	-124	-27	0	0	0	-	-	-	-
Comprehensive income (loss)
-52,524	-84,093	-114,807	-110,730	-108,663	-102,566	-92,547	-89,502	-92,536	-92,226	-90,482	-85,998	-78,934	-74,363	-56,737	-37,399	-30,850	-31,712	-49,279	-60,276	-67,449	-66,165	-64,404	-75,696	-77,068	-79,309	-83,786	-86,050	-88,113	-94,492	-95,549	-102,277	-102,027	-109,310	0	0	0
Net income (loss) per share:
Basic and diluted net loss per share
-	-	-0.19	-0.16	-	-0.20	-0.19	-0.17	-0.20	-0.16	-0.19	-0.26	-0.26	-0.20	-0.19	-0.21	-0.23	-	-	-0.16	-0.27	-	-	-0.27	-0.28	-0.25	-0.31	-0.33	-0.37	-0.38	-0.41	-0.40	-0.50	-0.41	-0.54	-0.42	-0.66
Shares used in computing basic and diluted net loss per share
-	-	152,983	152,776	-	149,596	135,130	131,882	123,768	116,627	115,771	97,360	92,970	92,730	92,110	88,148	83,604	-	-	74,733	74,149	-	-	70	67,861	66,319	65,523	61,922	57,372	56,196	55,877	55,658	55,201	161,106	54,283	53	52
Basic
0.01	-	-	-	-0.20	-	-	-	-	-	-	-	-	-	-	-	-	-	0.02	-	-	-	-0.13	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Diluted
0.01	-	-	-	-0.20	-	-	-	-	-	-	-	-	-	-	-	-	-	0.02	-	-	-	-0.13	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Weighted average shares outstanding used in calculating net income (loss) per share
Basic
153,453	-	-	-	151,274	-	-	-	-	-	-	-	-	-	-	-	-	-	75,205	-	-	-	70,740	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Diluted
155,855	-	-	-	151,274	-	-	-	-	-	-	-	-	-	-	-	-	-	80,479	-	-	-	70,740	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Product [Member]
Revenue
76,578	77,742	69,629	66,295	63,530	66,355	71,762	76,955	75,018	80,030	78,778	76,485	73,524	64,609	53,815	43,335	38,573	37,502	40,626	39,818	38,742	35,299	28,167	27,219	24,071	20,039	18,527	13,981	15,207	20,089	25,629	34,509	0	-	0	0	-
Cost of revenue
41,574	44,771	43,712	43,774	41,652	42,053	42,963	42,260	40,557	42,900	42,308	40,034	38,994	34,512	30,683	26,529	27,852	30,704	33,867	34,356	32,189	29,626	23,616	22,624	19,675	15,706	14,985	11,329	13,389	18,796	21,495	23,072	0	-	0	0	-
Service and Other [Member]
Revenue
13,486	13,149	12,858	12,437	12,159	12,271	12,273	12,465	12,897	13,438	14,131	14,401	14,440	13,971	13,074	12,353	11,307	10,896	10,295	9,709	9,171	8,511	7,873	7,315	6,782	6,446	7,073	6,749	6,586	5,894	4,155	3,064	0	-	0	0	-
Cost of revenue
11,543	11,544	11,385	11,290	11,120	11,477	12,228	13,281	14,340	15,909	15,408	14,844	13,915	12,042	11,338	10,378	9,385	8,628	8,116	7,722	7,755	7,566	7,055	6,766	6,405	6,056	6,083	6,145	6,112	6,247	5,488	4,056	0	-	0	0	-
Contractual [Member]
Revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	12,134	34,384	34,384	44,384	44,384	22,484	30,584	18,684	16,784	0	0	0	-	-	-	-	-	0	0	0	-	0	0	0